(Q39513395)

12 September 2017

title

Unravelling the antimetastatic potential of pentoxifylline, a methylxanthine derivative in human MDA-MB-231 breast cancer cells (English)

1 reference

12 September 2017

1 reference

Peeyush N Goel

1

1 reference

12 September 2017

R P Gude

series ordinal

2

1 reference

12 September 2017

publication date

3 July 2011

1 reference

Molecular and Cellular Biochemistry

12 September 2017

published in

1 reference

12 September 2017

volume

358

1 reference

12 September 2017

issue

1-2

1 reference

12 September 2017

page(s)

141-151

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Metastasis: from dissemination to organ-specific colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Drug treatment of intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Pentoxifylline attenuates cardiac dysfunction and reduces TNF-alpha level in ischemic-reperfused heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Inhibition of DNA repair by Pentoxifylline and related methylxanthine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Regulation of p53 by Mdm2: fate is in the numbers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Cyclooxygenase and cAMP-dependent protein kinase reorganize the actin cytoskeleton for motility in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Pentoxifylline impedes migration in B16F10 melanoma by modulating Rho GTPase activity and actin organisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Pentoxifylline modulates cell surface integrin expression and integrin mediated adhesion of B16F10 cells to extracellular matrix components.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Antiproliferative and antiproteolytic activity of pentoxifylline in cultures of B16F10 melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Clonogenic assay of cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

A simple technique for quantifying apoptosis in 96-well plates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

[6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Phosphodiesterase inhibitors as anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Breast cancer metastasis: markers and models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Cancer metastasis: building a framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

The price of innovation: new estimates of drug development costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

The type IV phosphodiesterase inhibitor rolipram induces expression of the cell cycle inhibitors p21(Cip1) and p27(Kip1), resulting in growth inhibition, increased differentiation, and subsequent apoptosis of malignant A-172 glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Valproate activates phosphodiesterase-mediated cAMP degradation: relevance to C6 glioma G1 phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Pentoxifylline inhibits platelet-derived growth factor-stimulated cyclin D1 expression in mesangial cells by blocking Akt membrane translocation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Responsiveness to PI3K and MEK inhibitors in breast cancer. Use of a 3D culture system to study pathways related to hormone independence in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Apoptosis: identification of dying cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Matrix metalloproteinases: regulators of the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Induction of secreted matrix metalloproteinase-9 activity in human melanoma cells by extracellular matrix proteins and cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0929-8

Differential regulation of TNF alpha, IL-1 beta, IL-6, IL-8, TNF beta, and IL-10 by pentoxifylline

21 January 2018

1 reference

12 December 2020

Pentoxifylline improves the oxygenation and radiation response of BA1112 rat rhabdomyosarcomas and EMT6 mouse mammary carcinomas

1 reference

12 December 2020

The inhibition of cancer cell stickness by the methylxanthine derivative pentoxifylline (BL 191)

1 reference

12 December 2020

Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer

1 reference

12 December 2020

Regulation of 92-kD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-alpha as an autocrine stimulus for basal- and phorbol ester-induced secretion

1 reference

12 December 2020

Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases.

1 reference

12 December 2020

10.1007/S11010-011-0929-8

Identifiers

DOI

1 reference

12 September 2017

1 reference